ZIM Corporation

ZIM Corporation

ZIMCF
ZIM CorporationUS flagOther OTC
0.00
USD
- -
- -
1,627.00Market Cap
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
TTM
Revenue per Share
0.38
0.28
0.31
0.29
0.2
0.19
0.16
0.08
0.08
0.06
- -
- -
- -
- -
Basic EPS, GAAP
0.03
0.05
0.06
0.07
-0.03
-0.05
-0.03
-0.04
-0.01
-0.01
0.09
- -
-0.01
0.03
Free Cash Flow per Basic Share
0.09
0.07
0.08
0.05
- -
-0.01
-0.01
-0.06
- -
- -
0.02
-0.03
-0.03
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-4.41
-3.7
-3.34
-3.21
-3.12
-3.05
-3
-2.85
-0.22
-0.23
-0.14
-0.14
-0.22
-0.23
Tangible Book Value per Share
0.16
0.25
0.33
0.38
0.33
0.25
0.17
0.12
0.1
0.09
0.17
0.15
0.14
0.12
Basic Weighted Avg Shares
5
6
6
6
7
7
7
7
8
8
8
8
8
8
Sales/Revenue/Turnover
2
2
2
2
1
1
1
1
1
1
- -
- -
- -
- -
Operating Margin (%)
-5.29
-6.96
19.59
22.15
-8.91
-19.65
-32.4
-59.52
-15.09
-20.72
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
Effective Tax Rate (%)
- -
- -
17.46
9.25
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
8.38
19.08
19.18
25.08
-15.34
-27.63
-20.85
-50.33
-10.35
-8.53
- -
- -
- -
- -
Working Capital
1
1
2
2
2
2
1
1
1
1
1
1
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
1
1
2
2
2
2
1
1
1
1
1
1
1
1
Return on Invested Capital (%)
- -
- -
17.55
16.05
- -
- -
- -
- -
- -
- -
-7.84
-5.26
- -
-4.19
Return on Capital (%)
- -
- -
-1.78
-2.25
- -
- -
- -
- -
- -
- -
-47.63
0.6
- -
-15.97
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Mar'21
Jun'22
Sep'22
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
8
8
8
Market Capitalization
1
- -
1

Working Capital

FRC

in mil. unless spec.
Mar'21
Jun'22
Sep'22
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-2.27%
9.82%
-7.92%
Free Cash Flow
-82.96%
-172.9%
13.39%
Net Income, GAAP
-125.4%
-241.24%
750.85%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
-0.01
0.02
-0.01
- -
- -
2021
0.01
-0.01
- -
- -
-0.01
2022
-0.01
-0.01
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Michael C. J. Cowpland
Full Time Employees
5
Sector
Technology
Industry
Software - Application
Address
150 Isabella Street Ottawa ON Canada K1S 1V7
IPO Date
Oct 16, 2003
Website
zim.biz
Business
ZIM Corporation (ZIMCF) develops and sells enterprise software products and services for database management and mobile applications. The company operates in two primary segments, Mobile and Enterprise Software; it provides ZIM integrated development environment (IDE) software, which supports the design, development, and management of information databases and mission-critical applications on Microsoft Windows, UNIX, and Linux operating systems; its products serve industries including finance, insurance, marketing, human resources, information, and records management; ZIM also offers migration services, management products, and short message services. ZIM Corporation maintains operations in the United States, Brazil, Canada, Singapore, and Austria. Founded in 1997, the company is headquartered at 150 Isabella Street, Suite 150, Ottawa, Ontario, Canada. In recent years, ZIM Corporation has shifted strategic focus toward accelerating research and growth in biomedical and emerging technology companies through Zim Investments; it supports disruptive technologies from research to commercialization across multiple industries, including a notable investment in NuvoBio, a bio-medical firm developing peptide therapeutics.

Company News

APIChat
  • Contrasting Microsoft (NASDAQ:MSFT) & ZIM (OTCMKTS:ZIMCF)

  • ZIM (OTCMKTS:ZIMCF) vs. Smith Micro Software (NASDAQ:SMSI) Head to Head Review

  • Manhattan Associates (NASDAQ:MANH) & ZIM (OTCMKTS:ZIMCF) Head to Head Contrast

  • Analyzing ZIM (OTCMKTS:ZIMCF) and The Descartes Systems Group (NASDAQ:DSGX)

  • Financial Analysis: ZIM (OTCMKTS:ZIMCF) and Rand Worldwide (OTCMKTS:RWWI)

  • Head to Head Analysis: ZIM (OTCMKTS:ZIMCF) versus Synopsys (NASDAQ:SNPS)